Free Trial

Premier (PINC) Competitors

$18.92
+0.19 (+1.01%)
(As of 05/31/2024 ET)

PINC vs. MANT, TMX, RCM, EVH, FC, IT, BIO.B, ASND, LEGN, and BRBR

Should you be buying Premier stock or one of its competitors? The main competitors of Premier include ManTech International (MANT), Terminix Global (TMX), R1 RCM (RCM), Evolent Health (EVH), Franklin Covey (FC), Gartner (IT), Bio-Rad Laboratories (BIO.B), Ascendis Pharma A/S (ASND), Legend Biotech (LEGN), and BellRing Brands (BRBR).

Premier vs.

Premier (NASDAQ:PINC) and ManTech International (NASDAQ:MANT) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, dividends, risk and community ranking.

Premier presently has a consensus target price of $23.50, suggesting a potential upside of 24.21%. Given Premier's higher probable upside, equities research analysts clearly believe Premier is more favorable than ManTech International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Premier
1 Sell rating(s)
10 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
ManTech International
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Premier has a beta of 0.39, indicating that its stock price is 61% less volatile than the S&P 500. Comparatively, ManTech International has a beta of 0.66, indicating that its stock price is 34% less volatile than the S&P 500.

74.4% of Premier shares are owned by institutional investors. Comparatively, 94.5% of ManTech International shares are owned by institutional investors. 0.9% of Premier shares are owned by company insiders. Comparatively, 1.4% of ManTech International shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Premier pays an annual dividend of $0.84 per share and has a dividend yield of 4.4%. ManTech International pays an annual dividend of $1.64 per share and has a dividend yield of 1.7%. Premier pays out 131.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. ManTech International pays out 55.2% of its earnings in the form of a dividend.

In the previous week, Premier had 15 more articles in the media than ManTech International. MarketBeat recorded 15 mentions for Premier and 0 mentions for ManTech International. Premier's average media sentiment score of 0.69 beat ManTech International's score of 0.00 indicating that Premier is being referred to more favorably in the media.

Company Overall Sentiment
Premier Positive
ManTech International Neutral

Premier has a net margin of 6.01% compared to ManTech International's net margin of 4.67%. Premier's return on equity of 11.71% beat ManTech International's return on equity.

Company Net Margins Return on Equity Return on Assets
Premier6.01% 11.71% 7.31%
ManTech International 4.67%8.00%5.28%

Premier received 267 more outperform votes than ManTech International when rated by MarketBeat users. Likewise, 69.00% of users gave Premier an outperform vote while only 50.15% of users gave ManTech International an outperform vote.

CompanyUnderperformOutperform
PremierOutperform Votes
612
69.00%
Underperform Votes
275
31.00%
ManTech InternationalOutperform Votes
345
50.15%
Underperform Votes
343
49.85%

Premier has higher earnings, but lower revenue than ManTech International. Premier is trading at a lower price-to-earnings ratio than ManTech International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Premier$1.34B1.48$175.03M$0.6429.56
ManTech International$2.55B1.54$137.02M$2.9732.32

Summary

Premier beats ManTech International on 11 of the 19 factors compared between the two stocks.

Get Premier News Delivered to You Automatically

Sign up to receive the latest news and ratings for PINC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PINC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PINC vs. The Competition

MetricPremierManagement services IndustryMedical SectorNASDAQ Exchange
Market Cap$1.98B$6.30B$5.13B$7.96B
Dividend Yield4.49%3.57%2.75%4.01%
P/E Ratio29.5616.90167.1718.57
Price / Sales1.4860.472,418.7891.65
Price / Cash5.3915.2035.3031.51
Price / Book1.039.955.534.59
Net Income$175.03M$225.26M$106.01M$213.90M
7 Day Performance-0.37%-1.92%1.14%0.87%
1 Month Performance-10.16%-4.51%1.43%3.60%
1 Year Performance-24.50%-11.11%4.07%7.91%

Premier Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MANT
ManTech International
0 of 5 stars
$95.98
flat
N/A+0.0%$3.93B$2.55B32.329,800Analyst Forecast
TMX
Terminix Global
0 of 5 stars
$37.87
flat
N/AN/A$4.61B$2.05B71.4511,700
RCM
R1 RCM
4.7554 of 5 stars
$12.99
+0.9%
$16.31
+25.5%
-21.7%$5.47B$2.25B-162.3830,000Positive News
EVH
Evolent Health
2.2597 of 5 stars
$21.53
+0.3%
$42.00
+95.1%
-29.0%$2.50B$1.96B-17.224,700News Coverage
FC
Franklin Covey
3.6084 of 5 stars
$36.59
+0.1%
$66.33
+81.3%
+0.1%$485.40M$279.13M29.751,160Analyst Forecast
Short Interest ↓
IT
Gartner
3.9368 of 5 stars
$419.00
-2.0%
$474.50
+13.2%
+23.3%$32.53B$5.90B41.6920,237Analyst Downgrade
BIO.B
Bio-Rad Laboratories
0 of 5 stars
$279.91
flat
N/A-25.1%$7.98B$2.67B-27.027,900Positive News
ASND
Ascendis Pharma A/S
3.2469 of 5 stars
$134.79
+1.7%
$176.88
+31.2%
+53.6%$7.85B$288.08M-14.03879Analyst Forecast
Short Interest ↓
LEGN
Legend Biotech
2.6005 of 5 stars
$42.78
+1.7%
$81.10
+89.6%
-37.1%$7.80B$285.14M-32.911,800
BRBR
BellRing Brands
2.6739 of 5 stars
$58.05
-0.5%
$62.23
+7.2%
+57.7%$7.57B$1.67B40.31420Analyst Revision
Positive News

Related Companies and Tools

This page (NASDAQ:PINC) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners